Pacira BioSciences Files 8-K for Bylaws and Exhibits
Ticker: PCRX · Form: 8-K · Filed: Mar 14, 2025 · CIK: 1396814
| Field | Detail |
|---|---|
| Company | Pacira Biosciences, Inc. (PCRX) |
| Form Type | 8-K |
| Filed Date | Mar 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, financial-reporting
Related Tickers: PCRX
TL;DR
Pacira BioSciences filed an 8-K for corporate updates and exhibits, no major news.
AI Summary
Pacira BioSciences, Inc. filed an 8-K on March 14, 2025, reporting events as of March 12, 2025. The filing primarily concerns amendments to its articles of incorporation or bylaws and the submission of financial statements and exhibits. No specific financial figures or significant business events were detailed in the provided excerpt.
Why It Matters
This filing indicates routine corporate governance updates and the submission of required financial documentation to the SEC.
Risk Assessment
Risk Level: low — The filing appears to be routine administrative and financial reporting, not indicating any immediate material changes or risks.
Key Numbers
- 001-35060 — SEC File Number (Identifies the company's filing with the SEC.)
- 51-0619477 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Pacira BioSciences, Inc. (company) — Registrant
- 2000 Sierra Point Parkway, Suite 900 (location) — Business Address
- Brisbane, California (location) — Business Address City and State
- 94005 (location) — Business Address Zip Code
FAQ
What specific amendments were made to Pacira BioSciences' articles of incorporation or bylaws?
The provided excerpt does not detail the specific amendments made to the articles of incorporation or bylaws; it only indicates that such amendments are part of the filing.
What financial statements and exhibits are included in this 8-K filing?
The excerpt states that financial statements and exhibits are included, but does not list their specific contents.
What is the significance of the 'Date as of Change' being March 12, 2025?
This date signifies the earliest event reported in the filing, indicating that the reported changes or submissions are effective as of March 12, 2025.
What was Pacira BioSciences, Inc. previously known as?
Pacira BioSciences, Inc. was formerly known as Pacira Pharmaceuticals, Inc. (name change effective October 29, 2010), PACIRA INC (name change effective March 18, 2008), and Blue Acquisition Corp (name change effective April 18, 2007).
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report amendments to the company's articles of incorporation or bylaws and to submit financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 14, 2025 regarding Pacira BioSciences, Inc. (PCRX).